에이프로젠

에이프로젠 has filed trades across 3 companies (mainly through DART (FSS)), most often in 에이프로젠바이오로직스, 앱튼 and 앱토크롬. We count 81 filings; the first trade dates from 24 June 2022 and the latest from 8 October 2026.

Both buying and selling appear: 40 purchases worth €7.6M, against 21 sales worth €1.2M. The amount is not disclosed for 59 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2026 to date brings 9 purchases and 8 sales.

None of the 35 purchases we analysed coincided with buying by another insider of the same company within 30 days.

On 8 October 2026 came the latest disclosure, a transaction in 에이프로젠바이오로직스. The last insider purchase was made public on 2 October 2026, 16 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 5 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.